SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sybille Merceron, Thomas Geeraerts, Claire Montlahuc, Jean-Pierre Bedos, Matthieu Resche-Rigon, Stéphane Legriel, Assessment of cerebral blood flow changes in nonconvulsive status epilepticus in comatose patients: A pathophysiological transcranial Doppler study, Seizure, 2014, 23, 4, 284

    CrossRef

  2. 2
    J. Stephen Huff, Edward R. Melnick, Christian A. Tomaszewski, Molly E.W. Thiessen, Andy S. Jagoda, Francis M. Fesmire, Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Seizures, Annals of Emergency Medicine, 2014, 63, 4, 437

    CrossRef

  3. 3
    Takahisa Hanada, Katsutoshi Ido, Takashi Kosasa, Effect of perampanel, a novel AMPA antagonist, on benzodiazepine-resistant status epilepticus in a lithium-pilocarpine rat model, Pharmacology Research & Perspectives, 2014, 2, 5
  4. 4
    Mercedes Garcés, Vicente Villanueva, José Angel Mauri, Ana Suller, Carolina García, Franscisco Javier López González, Xiana Rodríguez Osorio, Gustavo Fernández Pajarín, Anna Piera, Edelmira Guillamón, Consuelo Santafé, Ascensión Castillo, Pau Giner, Nerea Torres, Inés Escalza, Ana del Villar, Maria Carmen García de Casasola, Macarena Bonet, Enrique Noé, Nuria Olmedilla, Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study, Epilepsy & Behavior, 2014, 36, 144

    CrossRef

  5. 5
    Leena Kämppi, Harri Mustonen, Seppo Soinila, Factors Related to Delays in Pre-hospital Management of Status Epilepticus, Neurocritical Care, 2014,

    CrossRef

  6. 6
    J.M. Mercadé Cerdá, M. Toledo Argani, J.A. Mauri Llerda, F.J. López Gonzalez, X. Salas Puig, J. Sancho Rieger, Guía oficial de la Sociedad Española de Neurología de práctica clínica en epilepsia, Neurología, 2014,

    CrossRef

  7. 7
    Benjamin Legros, Chantal Depondt, Marcel Levy-Nogueira, Noémie Ligot, Nicolas Mavroudakis, Gilles Naeije, Nicolas Gaspard, Intravenous Lacosamide in Refractory Seizure Clusters and Status Epilepticus: Comparison of 200 and 400 mg Loading Doses, Neurocritical Care, 2014, 20, 3, 484

    CrossRef

  8. 8
    Salvatore Grosso, Nelia Zamponi, Arnaldo Bartocci, Elisabetta Cesaroni, Silvia Cappanera, Rosanna Di Bartolo, Paolo Balestri, Lacosamide in children with refractory status epilepticus. A multicenter Italian experience, European Journal of Paediatric Neurology, 2014, 18, 5, 604

    CrossRef

  9. 9
    Jan Claassen, David Albers, J. Michael Schmidt, Gian Marco De Marchis, Deborah Pugin, Christina Maria Falo, Stephan A. Mayer, Serge Cremers, Sachin Agarwal, Mitchell S. V. Elkind, E. Sander Connolly, Vanja Dukic, George Hripcsak, Neeraj Badjatia, Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome, Annals of Neurology, 2014, 75, 5
  10. 10
    M. Jeffrey, M. Lang, J. Gane, E. Chow, C. Wu, L. Zhang, Novel anticonvulsive effects of progesterone in a mouse model of hippocampal electrical kindling, Neuroscience, 2014, 257, 65

    CrossRef

  11. 11
    O. H. Hernandez, J. F. Zapata, M. Jimenez, M. Massaro, A. Guerra, J. C. Arango, J. D. Ciro, H. Delgado, J. I. Suarez, Refractory Status Epilepticus: Experience in a Neurological Intensive Care Unit, Journal of Critical Care Medicine, 2014, 2014, 1

    CrossRef

  12. 12
    Marco Mula, The safety and tolerability of intranasal midazolam in epilepsy, Expert Review of Neurotherapeutics, 2014, 14, 7, 735

    CrossRef

  13. 13
    Andrea O. Rossetti, Thomas P. Bleck, What’s new in status epilepticus?, Intensive Care Medicine, 2014,

    CrossRef

  14. 14
    Anne Sabers, Peter Wolf, Arne Møller, Karen Rysgaard, Elinor Ben-Menachem, A prospective, randomized, multicentre trial for the treatment of refractory status epilepticus; experiences from evaluating the effect of the novel drug candidate, NS1209, Epilepsy Research, 2013, 106, 1-2, 292

    CrossRef

  15. 15
    Melanie Jeffrey, Min Lang, Jonathan Gane, Chiping Wu, W Burnham, Liang Zhang, A reliable method for intracranial electrode implantation and chronic electrical stimulation in the mouse brain, BMC Neuroscience, 2013, 14, 1, 82

    CrossRef

  16. 16
    Leena Kämppi, Harri Mustonen, Seppo Soinila, Analysis of the Delay Components in the Treatment of Status Epilepticus, Neurocritical Care, 2013, 19, 1, 10

    CrossRef

  17. 17
    Jeffrey Buchhalter, Antonia Stang, Commentary on ‘Propofol versus thiopental sodium for the treatment of refractory status epilepticus—Still no answer’, Evidence-Based Child Health: A Cochrane Review Journal, 2013, 8, 4
  18. 18
    J. Miró, M. Toledo, E. Santamarina, A.C. Ricciardi, V. Villanueva, A. Pato, J. Ruiz, R. Juvany, M. Falip, Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: A multicentric prospective study, Seizure, 2013, 22, 1, 77

    CrossRef

  19. 19
    Julia Höfler, Eugen Trinka, Lacosamide as a new treatment option in status epilepticus, Epilepsia, 2013, 54, 3
  20. 20
    Stéphane Legriel, Julia Hilly-Ginoux, Matthieu Resche-Rigon, Sybille Merceron, Jeanne Pinoteau, Matthieu Henry-Lagarrigue, Fabrice Bruneel, Alexandre Nguyen, Pierre Guezennec, Gilles Troché, Olivier Richard, Fernando Pico, Jean-Pierre Bédos, Prognostic value of electrographic postanoxic status epilepticus in comatose cardiac-arrest survivors in the therapeutic hypothermia era, Resuscitation, 2013, 84, 3, 343

    CrossRef

  21. 21
    Raoul Sutter, Stephan Marsch, Stephan Rüegg, Safety and Efficacy of Intravenous Lacosamide for Adjunctive Treatment of Refractory Status Epilepticus: A Comparative Cohort Study, CNS Drugs, 2013, 27, 4, 321

    CrossRef

  22. 22
    Maxim Kozhemyakin, Karthik Rajasekaran, Marko S. Todorovic, Samuel L. Kowalski, Corinne Balint, Jaideep Kapur, Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus, Neurobiology of Disease, 2013, 54, 94

    CrossRef

  23. 23
    Ricardo Bernater, Analía Calle, Verónica Campanille, Oscar Martínez, Natalia Paoli, Mónica Perassolo, Lucas Martin Romano, Maria Belén Viaggio, Status epiléptico: actualización en consideraciones clínicas y guías terapéuticas, Neurología Argentina, 2013, 5, 2, 117

    CrossRef

  24. 24
    Lawrence J. Hirsch, Nicolas Gaspard, Status Epilepticus, CONTINUUM: Lifelong Learning in Neurology, 2013, 19, 767

    CrossRef

  25. 25
    Panayiotis N. Varelas, Marianna V. Spanaki, Marek A. Mirski, Status Epilepticus: An Update, Current Neurology and Neuroscience Reports, 2013, 13, 7

    CrossRef

  26. 26
    Thomas Bleck, Hannah Cock, James Chamberlain, James Cloyd, Jason Connor, Jordan Elm, Nathan Fountain, Elizabeth Jones, Daniel Lowenstein, Shlomo Shinnar, Robert Silbergleit, David Treiman, Eugen Trinka, Jaideep Kapur, The Established Status Epilepticus Trial 2013, Epilepsia, 2013, 54,
  27. 27
    Andrea O. Rossetti, Vincent Alvarez, Jean-Marie Januel, Bernard Burnand, Treatment deviating from guidelines does not influence status epilepticus prognosis, Journal of Neurology, 2013, 260, 2, 421

    CrossRef

  28. 28
    Estevo Santamarina, Manuel Toledo, Maria Sueiras, Miquel Raspall, Nadim Ailouti, Elena Lainez, Isabel Porta, R. Gracia, Manuel Quintana, Javier Alvarez-Sabín, Xavier Salas Puig, Usefulness of intravenous lacosamide in status epilepticus, Journal of Neurology, 2013, 260, 12, 3122

    CrossRef

  29. 29
    A. Perks, S. Cheema, R. Mohanraj, Anaesthesia and epilepsy, British Journal of Anaesthesia, 2012, 108, 4, 562

    CrossRef

  30. 30
    Martin J. Brodie, Patrick Kwan, Current position of phenobarbital in epilepsy and its future, Epilepsia, 2012, 53,
  31. 31
    Alexander B. Kowski, Hassan Kanaan, Friedhelm C. Schmitt, Martin Holtkamp, Deep hypothermia terminates status epilepticus — an experimental study, Brain Research, 2012, 1446, 119

    CrossRef

  32. 32
    J. Weissl, V. Hülsmeyer, C. Brauer, A. Tipold, L.L. Koskinen, K. Kyöstilä, H. Lohi, C. Sauter-Louis, M. Wolf, A. Fischer, Disease Progression and Treatment Response of Idiopathic Epilepsy in Australian Shepherd Dogs, Journal of Veterinary Internal Medicine, 2012, 26, 1
  33. 33
    Brandon Foreman, Lawrence J. Hirsch, Epilepsy Emergencies: Diagnosis and Management, Neurologic Clinics, 2012, 30, 1, 11

    CrossRef

  34. 34
    M Hardmeier, R Zimmermann, S Rüegg, M Pflüger, S Deuster, K Suter, M Donzelli, J Drewe, S Krähenbühl, P Fuhr, M Haschke, Intranasal Midazolam: Pharmacokinetics and Pharmacodynamics Assessed by Quantitative EEG in Healthy Volunteers, Clinical Pharmacology & Therapeutics, 2012, 91, 5, 856

    CrossRef

  35. 35
    Johan Zelano, Eva Kumlien, Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: A systematic review, Seizure, 2012, 21, 4, 233

    CrossRef

  36. 36
    Manuel Facundo Latini, Leonor Griselda Castellino, Lucas Martín Romano, Levetiracetam vía oral en el tratamiento del estatus epiléptico no convulsivo inicial y refractario, Neurología Argentina, 2012, 4, 1, 11

    CrossRef

  37. 37
    Léonore Jaques, Andrea O. Rossetti, Newer antiepileptic drugs in the treatment of status epilepticus: Impact on prognosis, Epilepsy & Behavior, 2012, 24, 1, 70

    CrossRef

  38. 38
    V. Stojanova, A. O. Rossetti, Oral topiramate as an add-on treatment for refractory status epilepticus, Acta Neurologica Scandinavica, 2012, 125, 2
  39. 39
    Aaron M. Cook, Amber Castle, Amy Green, Christine Lesch, Christopher Morrison, Denise Rhoney, Dennis Parker, Eljim Tesoro, Gretchen Brophy, Haley Goodwin, Jane Gokun, Jason Makii, Karen McAllen, Kathleen Bledsoe, Kiranpal Sangha, Kyle Weant, Norah Liang, Teresa Murphy-Human, Practice Variations in the Management of Status Epilepticus, Neurocritical Care, 2012, 17, 1, 24

    CrossRef

  40. 40
    Jina Hanna, Alistair Nichol, Status epilepticus: an intensive care medicine problem, Anaesthesia & Intensive Care Medicine, 2012, 13, 4, 148

    CrossRef

  41. 41
    S. Shorvon, M. Ferlisi, The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy, Brain, 2012, 135, 8, 2314

    CrossRef

  42. 42
    Robert G. Kowalski, Wendy C. Ziai, Richard N. Rees, J. Kent Werner, Grace Kim, Haley Goodwin, Romergryko G. Geocadin, Third-line antiepileptic therapy and outcome in status epilepticus, Critical Care Medicine, 2012, 40, 9, 2677

    CrossRef

  43. 43
    Christoph Kellinghaus, Florian Stögbauer, Treatment of status epilepticus in a large community hospital, Epilepsy & Behavior, 2012, 23, 3, 235

    CrossRef

  44. 44
    Felix Rosenow, Susanne Knake, Epilepsy, 2012,

    CrossRef

  45. 45
    Andrea O. Rossetti, Tracey A. Milligan, Serge Vulliémoz, Costas Michaelides, Manuel Bertschi, Jong Woo Lee, A Randomized Trial for the Treatment of Refractory Status Epilepticus, Neurocritical Care, 2011, 14, 1, 4

    CrossRef

  46. 46
    Y. H. El-Hayek, C. Wu, R. Chen, A. R. Al-Sharif, S. Huang, N. Patel, C. Du, C. A. Ruff, M. G. Fehlings, P. L. Carlen, L. Zhang, Acute Postischemic Seizures Are Associated with Increased Mortality and Brain Damage in Adult Mice, Cerebral Cortex, 2011, 21, 12, 2863

    CrossRef

  47. 47
    A. Merkenschlager, Algorithmus zum Vorgehen beim kindlichen Koma, Notfall + Rettungsmedizin, 2011, 14, 7, 535

    CrossRef

  48. 48
    Martin Smith, Anesthestic agents and status epilepticus, Epilepsia, 2011, 52,
  49. 49
    Lieven Lagae, Clinical practice, European Journal of Pediatrics, 2011, 170, 4, 413

    CrossRef

  50. 50
    Erich Schmutzhard, Bettina Pfausler, Complications of the management of status epilepticus in the intensive care unit, Epilepsia, 2011, 52,
  51. 51
    Woojun Kim, Se Yoon Kwon, A Hyun Cho, Sung Chul Lim, Yeong In Kim, Young-Min Shon, Effectiveness of Topiramate in Medically Complicated Patients with Status Epilepticus or Acute Refractory Seizures, Journal of Epilepsy Research, 2011, 1, 2, 52

    CrossRef

  52. 52
    Kristin Rantsch, Uwe Walter, Matthias Wittstock, Reiner Benecke, Johannes Rösche, Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus, Seizure, 2011, 20, 7, 529

    CrossRef

  53. You have free access to this content53
    C. Kellinghaus, S. Berning, I. Immisch, J. Larch, F. Rosenow, A. O. Rossetti, C. Tilz, E. Trinka, Intravenous lacosamide for treatment of status epilepticus, Acta Neurologica Scandinavica, 2011, 123, 2
  54. 54
    Julia Höfler, Iris Unterberger, Judith Dobesberger, Giorgi Kuchukhidze, Gerald Walser, Eugen Trinka, Intravenous lacosamide in status epilepticus and seizure clusters, Epilepsia, 2011, 52, 10
  55. 55
    Andrea O Rossetti, Daniel H Lowenstein, Management of refractory status epilepticus in adults: still more questions than answers, The Lancet Neurology, 2011, 10, 10, 922

    CrossRef

  56. 56
    Poh-Shiow Yeh, Hsiu-Nien Shen, Tai-Yuan Chen, Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient, Seizure, 2011, 20, 9, 723

    CrossRef

  57. 57
    Kjersti Nesheim Power, Hans Flaatten, Nils Erik Gilhus, Bernt A. Engelsen, Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome, Epilepsy Research, 2011, 94, 1-2, 53

    CrossRef

  58. 58
    J. Salas-Puig, M. Toledo Argany, A. Jimeno, Protocolo diagnóstico y terapéutico del status epilepticus, Medicine - Programa de Formación Médica Continuada Acreditado, 2011, 10, 74, 5046

    CrossRef

  59. 59
    Anthony H. V. Schapira, Matti Hillbom, Publishing changes and information delivery in the clinical neurosciences, European Journal of Neurology, 2011, 18, 12
  60. 60
    Vincent Alvarez, Jean-Marie Januel, Bernard Burnand, Andrea O. Rossetti, Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam, Epilepsia, 2011, 52, 7
  61. 61
    Andrea O. Rossetti, Martin Holtkamp, Selection bias in analysis of status epilepticus in the intensive care unit, Critical Care Medicine, 2011, 39, 4, 927

    CrossRef

  62. 62
    Stéphane Legriel, Elie Azoulay, Selection bias in analysis of status epilepticus in the intensive care unit, Critical Care Medicine, 2011, 39, 4, 928

    CrossRef

  63. 63
    Soeren Boegevig, Anders Rothe, Jacob Tfelt-Hansen, Lotte C.G. Hoegberg, Successful reversal of life threatening cardiac effect following dosulepin overdose using intravenous lipid emulsion, Clinical Toxicology, 2011, 49, 4, 337

    CrossRef

  64. 64
    Simon Shorvon, The treatment of status epilepticus, Current Opinion in Neurology, 2011, 24, 2, 165

    CrossRef

  65. 65
    S. Shorvon, M. Ferlisi, The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol, Brain, 2011, 134, 10, 2802

    CrossRef

  66. 66
    Martin Holtkamp, Treatment strategies for refractory status epilepticus, Current Opinion in Critical Care, 2011, 17, 2, 94

    CrossRef

  67. 67
    W. B. Chen, R. Gao, Y. Y. Su, J. W. Zhao, Y. Z. Zhang, L. Wang, Y. Ren, C. Q. Fan, Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study, European Journal of Neurology, 2011, 18, 12
  68. 68
    R. Galvin, G. Bråthen, A. Ivashynka, M. Hillbom, R. Tanasescu, M. A. Leone, EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy, European Journal of Neurology, 2010, 17, 12
  69. 69
    R. Galvin, G. Brathen, A. Ivashynka, M. Hillbom, R. Tanasescu, M. A. Leone, Diagnosis, Therapy and Prevention of Wernicke's Encephalopathy,
  70. 70
    Nicolas Gaspard, Lawrence J. Hirsch, Recognizing, Assessing, and Treating Seizures and Status Epilepticus in the ICU,